These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 6345018
1. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. Garay G, Milone J, Dibar E, Pavlovsky S, Kvicala R, Sackmann Muriel F, Montres Varela D, Eppinger-Helft M. Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018 [Abstract] [Full Text] [Related]
2. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia. Vats TS, Mehta P, Trueworthy RC, Smith SD, Klopovich P. Cancer; 1981 Jun 15; 47(12):2789-92. PubMed ID: 6942907 [Abstract] [Full Text] [Related]
3. Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse. Pavlovsky S, Muriel FS, Eppinger-Helft M, Bustelo P, Garay G, Giuntoli JM, Kvicala R, Divito J, Picón A. Cancer Treat Rep; 1983 May 15; 67(5):425-7. PubMed ID: 6573958 [Abstract] [Full Text] [Related]
4. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B. Ettinger LJ, Brecher M, Coleman M, Smithson WA, Patterson R, Russell EC, Necheles T, Jones B, Ohnuma T. Med Pediatr Oncol; 1982 May 15; 10(1):35-43. PubMed ID: 7038420 [Abstract] [Full Text] [Related]
5. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial. Anderson J, Krivit W, Chilcote R, Pyesmany A, Chard R, Hammond D. Cancer Treat Rep; 1981 May 15; 65(11-12):1015-9. PubMed ID: 6945911 [Abstract] [Full Text] [Related]
6. Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia. Holton CP, Vietti TJ, Nora AH, Donaldson MH, Stuckey WJ, Watkins WL, Lane DM. N Engl J Med; 1969 Jan 23; 280(4):171-4. PubMed ID: 5248383 [No Abstract] [Full Text] [Related]
12. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Vats T, Buchanan G, Mehta P, Ragab A, Hvizdale E, Nitschke R, Link M, Beardsley GP, Maybee D, Krischer J. Invest New Drugs; 1992 Aug 23; 10(3):231-4. PubMed ID: 1428733 [Abstract] [Full Text] [Related]
18. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia. Sackmann-Muriel F, Svarch E, Eppinger-Helft M, Braier JL, Pavlovsky S, Guman L, Vergara B, Ponzinibbio C, Failace R, Garay GE, Bugnard E, Ojeda FG, De Bellis R, de Sijvarger SR, Saslavsky J. Cancer; 1978 Oct 23; 42(4):1730-40. PubMed ID: 101296 [Abstract] [Full Text] [Related]
19. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone]. Yoshikawa H, Sao H, Tahara T, Akao Y, Yoshikawa S. Gan To Kagaku Ryoho; 1984 Mar 23; 11(3):515-20. PubMed ID: 6584088 [Abstract] [Full Text] [Related]
20. Remission induction with daunomycin, vincristine, and prednisone in adult acute lymphocytic leukemia. Einhorn LH, Bond WH. Oncology; 1977 Mar 23; 34(1):25-8. PubMed ID: 266674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]